1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Neuland Laboratories Limited

Neuland Laboratories Limited

NEULANDLAB.BO
Neuland Laboratories LimitedIN flagBombay Stock Exchange
18,858.95
INR
-57.50
- -
242.31BMarket Cap

Total Valuation

Neuland Laboratories Limited carries a market capitalization of 242.31B, placing it among publicly traded companies globally. Its enterprise value stands at 153.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap242.31B
Enterprise Value153.56B

Share Statistics

Neuland Laboratories Limited currently has 12.83M shares outstanding.

Shares Outstanding12.83M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Neuland Laboratories Limited trades at a trailing price-to-earnings ratio of 42.35. The price-to-sales ratio is 7.62, and the price-to-book ratio stands at 1,194.84.

PE Ratio42.35
PS Ratio7.62
PB Ratio1,194.84
P/TBV Ratio9.70
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Neuland Laboratories Limited trades at an EV/EBITDA multiple of 31.81 and an EV/FCF ratio of 861.41. The EV/Sales ratio of 7.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.81 provides insight into valuation relative to core operating earnings.

EV / Sales7.59
EV / EBITDA31.81
EV / EBIT31.81
EV / FCF861.41

Financial Position

Neuland Laboratories Limited maintains a current ratio of 2.09, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.07, indicating elevated leverage, while an interest coverage ratio of 20.16 demonstrates strong ability to service its debt obligations.

Current Ratio2.09
Quick Ratio0.51
Debt / Equity16.07
Debt / EBITDA0.62
Interest Coverage20.16

Financial Efficiency

Neuland Laboratories Limited posts a return on equity of 71.34 and a return on invested capital of 18.56.

Return on Equity (ROE)71.34
Return on Assets (ROA)14.25
Return on Invested Capital (ROIC)18.56
Return on Capital Employed (ROCE)51.64
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.11

Taxes

Over the trailing twelve months, Neuland Laboratories Limited has paid 1.25B in income taxes, reflecting an effective tax rate of 25.56.

Income Tax1.25B
Effective Tax Rate25.56

Stock Price Statistics

Neuland Laboratories Limited's stock has gained approximately 59.99992% over the past 52 weeks. The 50-day moving average sits at 16,937.93, while the 200-day moving average is 15,290.37.

Beta (5Y)N/A
52-Week Price Change59.99992%
50-Day Moving Average16,937.93
200-Day Moving Average15,290.37
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Neuland Laboratories Limited generated 20.23B in revenue and converted that into 3.64B in net income, yielding earnings per share of 283.68. EBITDA reached 4.83B, while operating income came in at 4.83B.

Revenue20.23B
Gross Profit10.76B
Operating Income4.83B
Pretax Income4.89B
Net Income3.64B
EBITDA4.83B
EBIT4.83B
Earnings Per Share (EPS)283.68

Balance Sheet

Neuland Laboratories Limited holds 3.59B in cash and equivalents against 3.01B in total debt, resulting in a net debt position of 1.20B. Total book value stands at 129.01M, with working capital of 7.73B providing operational flexibility.

Cash & Cash Equivalents3.59B
Total Debt3.01B
Net Debt1.20B
Equity (Book Value)129.01M
Book Value Per Share10.05
Working Capital7.73B

Margins

Neuland Laboratories Limited operates with a gross margin of 53.18, reflecting its pricing power and cost economics. The operating margin of 23.86 and net profit margin of 17.99 provide insight into operational efficiency.

Gross Margin53.18
Operating Margin23.86
Pretax Margin24.17
Profit Margin17.99
EBITDA Margin23.86

Stock Splits

Neuland Laboratories Limited's most recent stock split took place on August 13, 2014 with a 500:523 split ratio.

Last Split Date8/13/2014
Split Ratio500:523

Scores

Neuland Laboratories Limited posts an Altman Z-Score of 10.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score10.48